核医学结合放射影像学诊断SAPHO综合征1例

2018-06-10 赵青 王立 吴庆军 协和医学杂志

女性,41岁,因“胸锁骨疼痛1年,颈肩和腰背痛8个月,手足脓疱疹3个月”于2011年11月9日入院。

【一般资料】

女性,41岁

【主诉】

因“胸锁骨疼痛1年,颈肩和腰背痛8个月,手足脓疱疹3个月”于2011年11月9日入院。

【现病史】

2011年8月患者双手足掌面分批出现脓疱样皮疹。MRI示第6颈椎(C6)、L1及L2椎体长T1长T2信号,L1椎体破坏(图1)。[18F]FDG-PET/CT显示C6椎体、L1椎体前下缘及双侧第1胸肋关节多发结节状高代谢病灶(PET,SUV平均值1.7~3.3);CT显示上述病变为轻度骨质破坏,局部骨质硬化和肥厚;C6椎体压缩性骨折(图2,3)。









【既往史】

患者2010年1O月“上感"后出现胸骨、锁骨及胸锁关节疼痛,无红肿。2011年3月上述症状加重,出现颈肩及腰背部疼痛和僵硬,晨起为重。外院查血沉及C反应蛋白明显升高;类风湿因子、抗核抗体、抗双链DNA及抗可提取核抗原抗体均阴性,HLA.B27阳性。骨扫描示双侧胸锁关节,右侧第5前肋,第1、4腰椎(L1、L4)异常放射性增高。拟诊为“强直性脊柱炎",间断应用泼尼松、甲氨蝶呤、柳氮磺胺吡啶及重组人Ⅱ型肿瘤坏死因子受体.抗体融合蛋白(益赛普25mg,皮下注射,每1~2周1次)治疗3月余,症状稍好转。

【体格检查】

双侧胸锁关节及锁骨近端饱满,压痛阳性;双侧肩关节压痛阳性,C6-7、T1-3及L3椎体棘突及椎旁压痛阳性,颈部活动、左肩内收和外旋功能显著受限;双侧“4"字试验阴性,Schober试验、指地距和枕墙距均正常,四肢关节检查未见异常。心肺和腹部查体未见异常。

【辅助检查

血、尿常规及肝肾功能正常,血沉96mm/h,超敏C反应蛋白120mg/L;乙肝五项、抗丙肝肝炎病毒抗体、抗人类免疫缺陷病毒抗体、结核菌干扰素γ释放试验均阴性。骨扫描提示颈椎、双侧胸锁关节、右第5前肋和第2腰椎放射性增高区(图5)。



诊断

综合临床表现和辅助检查,确诊为“SAPHO综合征"。

【治疗经过】

遂行C6椎体固定术,病理显示骨质中较多淋巴细胞浸润。入院查体见双手足散在大小不一脓疱样皮疹(图4)。予以英夫利西单抗(类克200mg/次,0、2、6、14周)联合甲氨蝶呤治疗,患者症状明显改善,血沉和C反应蛋白恢复正常。

原始出处:

赵青, 王立, 吴庆军,等. 核医学结合放射影像学诊断SAPHO综合征1例[J]. 协和医学杂志, 2013, 4(1):69-72.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2060646, encodeId=0677206064655, content=<a href='/topic/show?id=0d1f50290a8' target=_blank style='color:#2F92EE;'>#影像学诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50290, encryptionId=0d1f50290a8, topicName=影像学诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Mon Mar 25 16:06:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898179, encodeId=ceac18981e948, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15879, encryptionId=8904158e9e7, topicName=SAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Dec 20 06:06:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431235, encodeId=5f661431235d4, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616485, encodeId=8030161648570, content=<a href='/topic/show?id=c4e56205696' target=_blank style='color:#2F92EE;'>#核医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62056, encryptionId=c4e56205696, topicName=核医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e9619763557, createdName=12498bb3m96(暂无昵称), createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2060646, encodeId=0677206064655, content=<a href='/topic/show?id=0d1f50290a8' target=_blank style='color:#2F92EE;'>#影像学诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50290, encryptionId=0d1f50290a8, topicName=影像学诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Mon Mar 25 16:06:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898179, encodeId=ceac18981e948, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15879, encryptionId=8904158e9e7, topicName=SAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Dec 20 06:06:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431235, encodeId=5f661431235d4, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616485, encodeId=8030161648570, content=<a href='/topic/show?id=c4e56205696' target=_blank style='color:#2F92EE;'>#核医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62056, encryptionId=c4e56205696, topicName=核医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e9619763557, createdName=12498bb3m96(暂无昵称), createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
    2018-12-20 zz70
  3. [GetPortalCommentsPageByObjectIdResponse(id=2060646, encodeId=0677206064655, content=<a href='/topic/show?id=0d1f50290a8' target=_blank style='color:#2F92EE;'>#影像学诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50290, encryptionId=0d1f50290a8, topicName=影像学诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Mon Mar 25 16:06:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898179, encodeId=ceac18981e948, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15879, encryptionId=8904158e9e7, topicName=SAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Dec 20 06:06:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431235, encodeId=5f661431235d4, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616485, encodeId=8030161648570, content=<a href='/topic/show?id=c4e56205696' target=_blank style='color:#2F92EE;'>#核医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62056, encryptionId=c4e56205696, topicName=核医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e9619763557, createdName=12498bb3m96(暂无昵称), createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2060646, encodeId=0677206064655, content=<a href='/topic/show?id=0d1f50290a8' target=_blank style='color:#2F92EE;'>#影像学诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50290, encryptionId=0d1f50290a8, topicName=影像学诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa4f352, createdName=chenlianhui, createdTime=Mon Mar 25 16:06:00 CST 2019, time=2019-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1898179, encodeId=ceac18981e948, content=<a href='/topic/show?id=8904158e9e7' target=_blank style='color:#2F92EE;'>#SAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15879, encryptionId=8904158e9e7, topicName=SAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Thu Dec 20 06:06:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431235, encodeId=5f661431235d4, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616485, encodeId=8030161648570, content=<a href='/topic/show?id=c4e56205696' target=_blank style='color:#2F92EE;'>#核医学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62056, encryptionId=c4e56205696, topicName=核医学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e9619763557, createdName=12498bb3m96(暂无昵称), createdTime=Tue Jun 12 13:06:00 CST 2018, time=2018-06-12, status=1, ipAttribution=)]

相关资讯

影像放射领域十大第一期刊审稿周期及中国论文发表盘点

/* Style Definitions */ table.MsoNormalTable {mso-style-name:普通表格; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:"";

Advanced Accelerator Applications 旗下LUTATHERA获批用于胃肠胰神经内分泌肿瘤治疗

作为诺华公司的一员,Advanced Accelerator Applications S.A现已发展成为一家核医学领域的领导者,该公司于2018年1月26日宣布,其旗下的LUTATHERA的新药申请(new drug application,NDA)已经获得了美国FDA的批准用于治疗生长抑素受体阳性的胃肠胰神经内分泌肿瘤(GEP-NETs),包括成人的前肠,中肠和后肠神经内分泌肿瘤

不知道核医学?你OUT啦

核医学科究竟是干嘛的?每每聊天聊起自己的工作时,总会收获各种稀奇古怪让人头大的问题,累觉不爱了!其实核医学科在发达国家那是遍地开花,美国区区3亿多人口却有12000多台核医学设备,而在我们13多亿人口的泱泱大国却只有800台核医学设备,目前主要集中在500多家三级医院。 那么核医学究竟是做什么的,能诊治哪些疾病呢?就让我们一起来揭开核医学科的神秘面纱吧! Wha

临床核医学辐射安全专家共识

辐射安全是临床核医学的重要组成部分,也是临床核医学工作中的重要和关键内容之一,日常工作中应用较多且备受关注。但目前国内尚缺乏临床核医学辐射安全指导性文件。为使临床核医学工作开展得更规范,中华医学会核医学分会编写了《临床核医学辐射安全专家共识》(以下简称《共识》)。《共识》编写参照国际机构和中华人民共和国国家标准进行,编写组参阅大量国内外权威指南、规范、教材、专著、文献及相关政策法规,并经核医学、放